Genomind, LLC: Clinical Trials

7 trials sponsored by Genomind, LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated, 1 withdrawn. 6 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 4, Terminated 1, Withdrawn 1

Follow Genomind, LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population
Genecept Assay and G-DIG decision tool - Pharmacogenetic Testing
CompletedSeattle Institute for Biomedical and Clinical Research532018-01-012024-04-23
McLean and Genomind Prospective Study
Phlebotomy - Folate, Cheek Swab, Self-report surveys - Major Depressive Disorder, PTSD
Not applicableCompletedMclean Hospital752017-09-222021-02-23
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
Assay-guided treatment (AGT), Treatment-as-usual (TAU) - Major Depressive Disorder
Not applicableCompletedGenomind, LLC3052016-01-012020-08-28
An Open Label Study of the Genecept™ Assay in Treatment Resistant Depression
Genecept Assay - Major Depressive Disorder
Not applicableWithdrawnGenomind, LLC2015-01-012015-03-23
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis
PGx testing guided treatment (PGT) - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedNorthwell Health362014-07-102018-01-24
An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay
Genecept Assay - Treatment Resistant Depression, Generalized Anxiety Disorder
Not applicableCompletedGenomind, LLC6852013-04-012016-06-08
Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)
Genecept Assay - Major Depressive Disorder
Not applicableTerminatedGenomind, LLC292011-09-012021-09-13

Conditions studied

Depressive Disorder, Major (4)  ·  Depression (3)  ·  Disease (2)  ·  Anxiety Disorders (1)  ·  Bipolar Disorder (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Generalized Anxiety Disorder (1)  ·  Mental Disorders (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)  ·  Stress Disorders, Post-Traumatic (1)

Interventions

Genetic Testing (3)

Countries

United States (7)

Top investigators

Amanda E Wood, PhD. (1)  ·  David Krause, MD (1)  ·  Herb Harris, MD, PhD (1)  ·  Herbert Harris, MD, PhD (1)  ·  Jianping Zhang, MD, PhD (1)  ·  Kerry J Ressler, MD PhD (1)  ·  Rachel Dicker, PharmD (1)

Results publications

PMID 26445691, PMID 35075665